Letter: Unaddressed Confounders in the Evaluation of the Inflammatory Prognostic Index for CIN Prediction in STEMI

Abstract

Get full access to this article

View all access options for this article.

References

Can

Eynel

Özdemir

, et al. Inflammatory prognostic index may predict the development of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction. Angiology. 2026. doi:10.1177/00033197261447011

Redfors

Furer

Selker

, et al. Effect of smoking on outcomes of primary PCI in patients with STEMI. J Am Coll Cardiol. 2020;75(15):1743-1754. doi:10.1016/j.jacc.2020.02.045

Aune

Røislien

Mathisen

Thelle

Otterstad

JE.

The “smoker’s paradox” in patients with acute coronary syndrome: a systematic review. BMC Med. 2011;9:97. doi:10.1186/1741-7015-9-97

Weisz

Cox

Garcia

, et al. Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction—the smoker’s paradox revisited. Am Heart J. 2005;150(2):358-364. doi:10.1016/j.ahj.2004.01.032

Gurm

Dixon

Smith

, et al. Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions. J Am Coll Cardiol. 2011;58(9):907-914. doi:10.1016/j.jacc.2011.05.023

Mehran

Aymong

Nikolsky

, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44(7):1393-1399. doi:10.1016/j.jacc.2004.06.068

Sgura

Bertelli

Monopoli

, et al. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation myocardial infarction. Circ Cardiovasc Interv. 2010;3(5):491-498. doi:10.1161/CIRCINTERVENTIONS.110.955310